Ridgeback Biotherapeutics CEO Wendy Holman on human trials on COVID-19 treatment

Wendy Holman, Ridgeback Biotherapeutics co-founder and CEO, joins "Squawk on the Street" to discuss the FDA approval to begin human clinical trials on a new coronavirus treatment.